Q3 2014 13F Holders as of 9/30/2014
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
177M
-
Number of holders
-
33
-
Total 13F shares, excl. options
-
4.63M
-
Shares change
-
+4.63M
-
Total reported value, excl. options
-
$69.3M
-
Value change
-
+$69.3M
-
Number of buys
-
33
-
Price
-
$14.97
Significant Holders of OCULAR THERAPEUTIX, INC - Common Stock, $0.0001 par value per share (OCUL) as of Q3 2014
33 filings reported holding OCUL - OCULAR THERAPEUTIX, INC - Common Stock, $0.0001 par value per share as of Q3 2014.
OCULAR THERAPEUTIX, INC - Common Stock, $0.0001 par value per share (OCUL) has 33 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4.63M shares
of 177M outstanding shares and own 2.62% of the company stock.
Largest 10 shareholders include WELLINGTON MANAGEMENT CO LLP (1.29M shares), Capital Research Global Investors (921K shares), RS INVESTMENT MANAGEMENT CO LLC (611K shares), Pentwater Capital Management LP (490K shares), FEDERATED INVESTORS INC /PA/ (350K shares), SABBY MANAGEMENT, LLC (297K shares), BlackRock Fund Advisors (142K shares), DEUTSCHE BANK AG\ (100K shares), BlackRock Institutional Trust Company, N.A. (80.4K shares), and MORGAN STANLEY (66.2K shares).
This table shows the top 33 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.